Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4466790 | 5658981 | I | 4466790-7 | 20040629 | 20040923 | 20040930 | EXP | TPA2004A01146 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 73 | YR | F | N | 148 | LBS | 20040929 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4466790 | 1005268356 | PS | ACTOS | 1 | ORAL | PER ORAL | U | D | 21073 | ||
| 4466790 | 1005290462 | SS | PREDNISONE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4466790 | 1005268356 | DIABETES MELLITUS |
| 4466790 | 1005290462 | CEREBROVASCULAR ACCIDENT |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4466790 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4466790 | BLOOD GLUCOSE INCREASED |
| 4466790 | CEREBROVASCULAR ACCIDENT |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4466790 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4466790 | 1005268356 | 20040629 |